You are on page 1of 7

7 March 2024, 2:50PM UTC

Chief Investment Office GWM


Investment Research

India monthly outlook


Investing in India
Author: Premal Kamdar, Analyst, UBS Securities India

• We believe India offers the best structural growth


story among other large economies. Combined with
political stability and supportive government policies,
India remains in a favorable position and is most
preferred in our Asia ex-Japan asset class preferences
among equities.
• We expect the Indian equity market to remain
volatile in the near term as geopolitical and economic
risks remain elevated. However, we recommend
investors use any steep market corrections as buying
opportunities given the long-term structural growth
opportunities. We prefer domestic economy linked
sectors as they should benefit from India's superior Source: UBS
economic growth.
• Within fixed income, we believe Indian bond yields
will likely remain range bound in the near term.
Given the flatness of the yield curve, medium- to
long-duration bonds appear attractive as the elevated
levels offer good carry with duration over the next 12
months, in our view.
• We expect the INR to strengthen against the USD,
supported by an improving trade balance, healthy
forex reserves, stable oil prices and anticipation of FPI
inflows in debt (supported by index inclusion) and
equities (on reversal of interest rate cycle).

India’s GDP growth has been surprising positively, averaging risk premium falls. We believe the beginning of the rate cut
above 8.0% in the first three quarters of FY2024. We cycle will also be positive for fixed income markets and see
expect this momentum to continue as cyclical recovery a good opportunity to add duration. We prefer medium to
and structural improvements remain in play. That said, the long duration bonds. Lastly, we believe the INR could remain
current global conditions may cause growth to moderate. resilient, supported by a stable external deficit and rising
Even after factoring in any slowdown, we believe India could forex reserves.
still deliver 7% growth in FY2025.

While India’s stock market valuation is one standard


deviation above its 10-year average, we believe downside
risks are manageable amid a supportive domestic macro and
micro environment. Additionally, we believe the reversal of
the rate cycle could be valuation supportive as the equity

This report has been prepared by UBS Securities India. Please see important disclaimers and disclosures at the end of
the document.
Investing in India

Key policy trends


• The fiscal deficit narrowed in January. The fiscal data
released for January shows government tax revenues
grew 16.5% y/y in January, while the April to January
2024 (FYTD) run rate was around 79% of the revised
budget estimates. On the other hand, government
expenditures fell by 14.0% y/y in January, while the
FYTD run rate was around ~75% of the revised budget
estimates. The FYTD fiscal deficit stood at 63.8% of the
revised estimates, narrowing from the previous year’s
67.8% led by tax collections and a decline in capital
Key economic data trends expenditures.
• India’s GDP growth surprised positively. India's real Outlook
GDP of 8.4% for 3QFY24 surprised positively, and
• We believe that India is likely to remain one of the
against expectations of a moderation during the quarter.
fastest growing global economies. However, we expect
The upside surprise was driven by a sharp jump in net
GDP growth to moderate due to global (weaker growth)
indirect taxes (+32% YoY). Meanwhile, the real gross
and local factors (softness in public capex). From 7.6%
value add (GVA), which excludes the impact of indirect
y/y growth in FY24E, we expect real GDP growth
taxes, decelerated to 6.5% (from 7.7% in Q2) and was
to moderate to 7.0% and 6.8% in FY25 and FY26
in line with our expectations. The details show that
respectively. Sector-wise, we expect some moderation in
investment growth (+12.2% y/y) remained robust in the
investment-led growth due to lower public capex, while
December quarter, while consumption growth (+2.7%)
see a gradual recovery in consumption growth driven by
remained soft.
a recovery in rural growth on expectations of a normal
• Lead economic indicators suggest continued monsoon (as projected by IMD).
resilience. The UBS India Composite Economic Indicator
(UBS India-CEI), a leading indicator using 15 high-
Figure 2: India real GDP growth
frequency data points, suggests sequential improvement
of 1.1% m/m in economic momentum on a seasonally
adjusted basis in January. Moreover, the recent survey
data showed demand conditions remain robust with
manufacturing PMI’s in February rising to a five-month
high of 56.9.

Figure 1: UBS India CEI

Source: CEIC, Haver, National Statistics, UBS forecasts, as of March 2024

Note: 31 March ending is Fiscal year ending

Source: UBS as of March 2024

02
Investing in India

gap between the FPI and DII ownership has narrowed


to just 3.5%, which suggests the dominance of FPI
flows on Indian equities is shrinking. However, with
FPI ownership at a decade low, we do not anticipate
significant outflows from current levels.

Figure 4 - BSE500 index shareholding ownership


pattern

Equity performance and valuation


• The Nifty 50 index has risen 3.1% ytd and recently
recorded a new all-time high on the back of strong
macro, healthy corporate earnings and steady domestic
institutional investor (DII) buying. The Nifty 50 index
currently trades at a 12-months forward P/E of 20.5x,
one standard deviation above its 10Y average.

Figure 3 - Nifty PE valuation (12 months forward)

Source: NSE, Capitaline, UBS, as of December 2023

Outlook
• After a strong run up of Indian equities, some profit
taking in the near term cannot be ruled out as economic
and geopolitical risks remain elevated. Nevertheless,
India remains in a sweet spot, in our view, and we
recommend investors to use any corrections as buying
opportunities given the long-term structural growth
opportunities that exist.
• The most common pushback on India is its premium
Source: Bloomberg, UBS as of March 2024
valuation. We believe the premium valuation is
justified by cyclical and structural tailwinds, and further
Key trends supported by political stability. Additionally, valuations
get support from falling equity risk premium as interest
• Earnings remain healthy. Q3 earnings growth rates fall. Given this backdrop, we believe India’s high
moderated from the strength seen in the previous valuation is sustainable. We expect the Nifty index to
two quarters but remained healthy and in line with reach 25,200 by Mar-25, implying an upside of 12%.
consensus. The 3QFY24 PAT for the Nifty 50 companies The Nifty target is based on Mar-26 EPS estimates of
grew 16.3% y/y (vs. 32.2% in Q2) driven by a INR 1,226 and a 12 month forward target PE multiple
robust performance of the domestic cyclical sectors of 20.6x.
and continued margin tailwinds. However, with most
margin tailwinds baked in, further margin expansion • We like autos, industrials, utilities, real estate, consumer
appears limited. While margins have started to peak, durables and healthcare sectors that have high domestic
we expect earnings growth could be anchored around exposure. We are neutral on Financials, FMCG, IT, Oil &
topline growth in the coming quarters. Based on these Gas, and Chemicals, while we are least preferred on the
assumptions, we expect the Nifty earnings growth of metals and telecom sectors.
14% and 12% for FY25 and FY26 respectively. Risks
• DII ownership of Indian equities getting closer • Key risks for Indian markets include unfavorable election
to FPIs. Recent shareholding patterns suggest the FPI outcomes, a delay to the start of the rate cut cycle
ownership of India equities (BSE500 index) of ~17.8% and geopolitical tensions in the Middle East (surge in oil
remains at a decade low, while DII’s share has reached prices).
a record high of ~14.3% supported DII inflows. The

03
Investing in India

goods and services inflation. We expect headline CPI and


core inflation to ease further on a gradual pull back in
food prices and contained core inflation, but supply side
shocks add upside risks.

Figure 6 - India CPI inflation and repo rate

Change in bond yields


• 10-year US bond yields have surged by 33bps ytd on
risks of a delay to the rate cutting cycle and a still hot
labor market. Indian bond yields, in contrast, have seen
a diverging trend, with the 10-year Indian Government
bond yield falling 11bps ytd to 7.06% amid ongoing
optimism about Indian government bond inclusion in
the global bond index, further boosted by lower-than-
expected net borrowing targets in the FY2025 interim
Source: Bloomberg, UBS as of February 2024
financial budget.

Figure 5 - Government bond yields (%) Outlook


• On the policy front, the RBI may continue with its
hawkish hold on rates as GDP growth remains strong
and inflation remains above target with repeated food
spikes posing upside risks. The continuous repricing of
Fed easing path could also weigh on the RBI’s decision
to start its rate cut cycle. We believe that the RBI could
act in the June quarter by shifting its stance to neutral
followed by a cumulative 50bps rate cut in the second
half of the year. Although the RBI remains cautious, fiscal
consolidation and bond-index-inclusion-related inflows
will likely see bond yields fall over the coming months.
We expect the 10-year Indian government bond yield to
decline to 6.25% by March 2025.
• Given this backdrop, we prefer medium- to long-
Source: Bloomberg, UBS as of March 2024 duration bonds. Historically, turning positive on the long-
duration bonds well ahead of the first-rate cut has
Key trends reaped returns. Thus, we believe it is a good time to
• FPI inflows surge in India’s debt market. The add long-duration Indian government bonds and AAA
inclusion of India’s government bonds in the JP Morgan corporate bonds.
Global Bond Index in June 2024 and in the Bloomberg Risks
index in January 2025 has fueled optimism among
foreign investors as seen in the surge in FPI flows (USD • Key risks for the Indian bond market include a delay
4.8bn ytd) into Indian debt markets. to the start of the US rate cut cycle, supply shocks
due to geopolitical tensions, higher food inflation
• Inflation moderated in January. Headline CPI inflation due to adverse weather conditions, and any negative
decelerated to 5.1% ytd (consensus at 5.0%) in January developments toward index inclusion.
(vs. 5.7% in December) driven by easing food prices.
Meanwhile, core inflation continued its downtrend
and was the lowest since November 2019. A drop
in January’s core inflation to 3.6% ytd (vs. 3.9% in
December) was due to a broad-based decline across

04
Investing in India

Outlook
• We expect India’s current account deficit to narrow to
0.8% of GDP in FY24E on the back of an improving
trade deficit. Heading into FY25, it modestly increases
to 1.3% of GDP on slowing global growth and
supported domestic demand. Overall, we expect the
current account deficit to remain well contained, thereby
supporting the INR in our view.

Figure 8: India's current account deficit


Performance
• The DXY index has strengthened ~3.0% since the start
of the year given strong January labor market and US
inflation data. Despite a stronger USD, the INR has stayed
relatively stable and appreciated by 0.4% ytd against the
USD. The Indian currency also outperformed most of its
Asian peers over the same period.

Figure 7 - Asian currency performance against the


USD

Source: Bloomberg, UBS forecasts as of March 2024

• Our global investment committee expects the US Fed


to start cutting rates this year. A rate cut cycle drives
weakness in the USD and tends to benefit emerging
market currencies, resulting in higher foreign inflows.
This backdrop, combined with India’s resilient domestic
economy, improving trade fundamentals, and healthy
forex reserves should strengthen the INR outlook. We
expect the INR to appreciate versus the USD over the
Source: Bloomberg, UBS as of February 2024
next 12 months.
Key trends Risks
• India’s trade balance improves in January. The • Key risks include a delay to the start of the rate cut cycle
services trade surplus reached an all-time of USD 16.8bn and a spike in crude oil prices above USD 100bbl, whih
in January driven by strong growth in services exports would lead to a detrioration in India’s trade balance.
(+17% y/y). Meanwhile, the goods trade deficit fell by
USD 2.3bn in January to USD 17.5bn (vs. USD 19.8bn
in December), largely driven by a broad-based decline in
imports. Overall, an improvement in January’s trade data
should provide a cushion for the current account deficit,
thereby supporting the INR in our view.
• India has healthy forex reserves. India’s forex reserves
of USD 619bn are currently the fourth largest globally
with an import cover of 11 months and 1.02 times
external debt. The forex reserves provide sufficient
headroom for the RBI to protect the Indian currency from
sharp depreciation during volatile times.

05
Investing in India

UBS Chief Investment Office's ("CIO") investment views are prepared and published by the Global Wealth Management business of UBS Switzerland
AG (regulated by FINMA in Switzerland) or its affiliates ("UBS"), part of UBS Group AG ("UBS Group"). UBS Group includes Credit Suisse AG, its
subsidiaries, branches and affiliates. Additional disclaimer relevant to Credit Suisse Wealth Management follows at the end of this section.
The investment views have been prepared in accordance with legal requirements designed to promote the independence of investment research.
Generic investment research – Risk information:
This publication is for your information only and is not intended as an offer, or a solicitation of an offer, to buy or sell any investment or other
specific product. The analysis contained herein does not constitute a personal recommendation or take into account the particular investment
objectives, investment strategies, financial situation and needs of any specific recipient. It is based on numerous assumptions. Different assumptions
could result in materially different results. Certain services and products are subject to legal restrictions and cannot be offered worldwide on an
unrestricted basis and/or may not be eligible for sale to all investors. All information and opinions expressed in this document were obtained from
sources believed to be reliable and in good faith, but no representation or warranty, express or implied, is made as to its accuracy or completeness
(other than disclosures relating to UBS). All information and opinions as well as any forecasts, estimates and market prices indicated are current
as of the date of this report, and are subject to change without notice. Opinions expressed herein may differ or be contrary to those expressed by
other business areas or divisions of UBS as a result of using different assumptions and/or criteria.
In no circumstances may this document or any of the information (including any forecast, value, index or other calculated amount ("Values")) be
used for any of the following purposes (i) valuation or accounting purposes; (ii) to determine the amounts due or payable, the price or the value of
any financial instrument or financial contract; or (iii) to measure the performance of any financial instrument including, without limitation, for the
purpose of tracking the return or performance of any Value or of defining the asset allocation of portfolio or of computing performance fees. By
receiving this document and the information you will be deemed to represent and warrant to UBS that you will not use this document or otherwise
rely on any of the information for any of the above purposes. UBS and any of its directors or employees may be entitled at any time to hold long
or short positions in investment instruments referred to herein, carry out transactions involving relevant investment instruments in the capacity of
principal or agent, or provide any other services or have officers, who serve as directors, either to/for the issuer, the investment instrument itself or
to/for any company commercially or financially affiliated to such issuers. At any time, investment decisions (including whether to buy, sell or hold
securities) made by UBS and its employees may differ from or be contrary to the opinions expressed in UBS research publications. Some investments
may not be readily realizable since the market in the securities is illiquid and therefore valuing the investment and identifying the risk to which
you are exposed may be difficult to quantify. UBS relies on information barriers to control the flow of information contained in one or more areas
within UBS, into other areas, units, divisions or affiliates of UBS. Futures and options trading is not suitable for every investor as there is a substantial
risk of loss, and losses in excess of an initial investment may occur. Past performance of an investment is no guarantee for its future performance.
Additional information will be made available upon request. Some investments may be subject to sudden and large falls in value and on realization
you may receive back less than you invested or may be required to pay more. Changes in foreign exchange rates may have an adverse effect on
the price, value or income of an investment. The analyst(s) responsible for the preparation of this report may interact with trading desk personnel,
sales personnel and other constituencies for the purpose of gathering, synthesizing and interpreting market information.
Different areas, groups, and personnel within UBS Group may produce and distribute separate research products independently of each other. For
example, research publications from CIO are produced by UBS Global Wealth Management. UBS Global Research is produced by UBS Investment
Bank. Research methodologies and rating systems of each separate research organization may differ, for example, in terms of investment
recommendations, investment horizon, model assumptions, and valuation methods. As a consequence, except for certain economic forecasts (for
which UBS CIO and UBS Global Research may collaborate), investment recommendations, ratings, price targets, and valuations provided by each
of the separate research organizations may be different, or inconsistent. You should refer to each relevant research product for the details as to
their methodologies and rating system. Not all clients may have access to all products from every organization. Each research product is subject
to the policies and procedures of the organization that produces it.
The compensation of the analyst(s) who prepared this report is determined exclusively by research management and senior management (not
including investment banking). Analyst compensation is not based on investment banking, sales and trading or principal trading revenues, however,
compensation may relate to the revenues of UBS Group as a whole, of which investment banking, sales and trading and principal trading are a part.
Tax treatment depends on the individual circumstances and may be subject to change in the future. UBS does not provide legal or tax advice and
makes no representations as to the tax treatment of assets or the investment returns thereon both in general or with reference to specific client's
circumstances and needs. We are of necessity unable to take into account the particular investment objectives, financial situation and needs of
our individual clients and we would recommend that you take financial and/or tax advice as to the implications (including tax) of investing in any
of the products mentioned herein.
This material may not be reproduced or copies circulated without prior authority of UBS. Unless otherwise agreed in writing UBS expressly prohibits
the distribution and transfer of this material to third parties for any reason. UBS accepts no liability whatsoever for any claims or lawsuits from any
third parties arising from the use or distribution of this material. This report is for distribution only under such circumstances as may be permitted by
applicable law. For information on the ways in which CIO manages conflicts and maintains independence of its investment views and publication
offering, and research and rating methodologies, please visit www.ubs.com/research-methodology. Additional information on the relevant authors
of this publication and other CIO publication(s) referenced in this report; and copies of any past reports on this topic; are available upon request
from your client advisor.
Important Information About Sustainable Investing Strategies: Sustainable investing strategies aim to consider and incorporate
environmental, social and governance (ESG) factors into investment process and portfolio construction. Strategies across geographies approach
ESG analysis and incorporate the findings in a variety of ways. Incorporating ESG factors or Sustainable Investing considerations may inhibit UBS’s
ability to participate in or to advise on certain investment opportunities that otherwise would be consistent with the Client’s investment objectives.
The returns on a portfolio incorporating ESG factors or Sustainable Investing considerations may be lower or higher than portfolios where ESG
factors, exclusions, or other sustainability issues are not considered by UBS, and the investment opportunities available to such portfolios may differ.
External Asset Managers / External Financial Consultants: In case this research or publication is provided to an External Asset Manager or
an External Financial Consultant, UBS expressly prohibits that it is redistributed by the External Asset Manager or the External Financial Consultant
and is made available to their clients and/or third parties.
USA: Distributed to US persons only by UBS Financial Services Inc. or UBS Securities LLC, subsidiaries of UBS AG. UBS Switzerland AG, UBS
Europe SE, UBS Bank, S.A., UBS Brasil Administradora de Valores Mobiliarios Ltda, UBS Asesores Mexico, S.A. de C.V., UBS SuMi TRUST Wealth
Management Co., Ltd., UBS Wealth Management Israel Ltd and UBS Menkul Degerler AS are affiliates of UBS AG. UBS Financial Services

06
Investing in India

Inc. accepts responsibility for the content of a report prepared by a non-US affiliate when it distributes reports to US persons. All
transactions by a US person in the securities mentioned in this report should be effected through a US-registered broker dealer
affiliated with UBS, and not through a non-US affiliate. The contents of this report have not been and will not be approved by any
securities or investment authority in the United States or elsewhere. UBS Financial Services Inc. is not acting as a municipal advisor to
any municipal entity or obligated person within the meaning of Section 15B of the Securities Exchange Act (the "Municipal Advisor
Rule") and the opinions or views contained herein are not intended to be, and do not constitute, advice within the meaning of the
Municipal Advisor Rule
For country information, please visit ubs.com/cio-country-disclaimer-gr or ask your client advisor for the full disclaimer.
Additional Disclaimer relevant to Credit Suisse Wealth Management
You receive this document in your capacity as a client of Credit Suisse Wealth Management. Your personal data will be processed in accordance
with the Credit Suisse privacy statement accessible at your domicile through the official Credit Suisse website https://www.credit-suisse.com. In
order to provide you with marketing materials concerning our products and services, UBS Group AG and its subsidiaries may process your basic
personal data (i.e. contact details such as name, e-mail address) until you notify us that you no longer wish to receive them. You can optout from
receiving these materials at any time by informing your Relationship Manager.
Except as otherwise specified herein and/or depending on the local Credit Suisse entity from which you are receiving this report, this report is
distributed by Credit Suisse AG, authorised and regulated by the Swiss Financial Market Supervisory Authority (FINMA). Credit Suisse AG is a UBS
Group company.
Version A/2024. CIO82652744
© UBS 2024.The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

07

You might also like